Palisade Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Palisade Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $218,746 - $278,983	-3,050 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $41,123 - $47,008	550 Added 22.0%	3,050 $236,000
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $75,510 - $84,790	-1,000 Reduced 28.57%	2,500 $209,000
Q1 2021 May 12, 2021	BUY	$74.73 - $90.69 $261,555 - $317,415	3,500 New	3,500 $264,000
Q4 2020 Feb 11, 2021	SELL	$72.61 - $90.2 $217,830 - $270,600	-3,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $215,610 - $393,090	3,000 New	3,000 $228,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.